Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 68.6
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
WeLeader Biomedical Co. Ltd. engages in the production and sale of medical diagnostic equipment and materials. It provides serum biochemistry integration platform, clinical care and medical information integration systems. The company was founded on April 28, 2003 and is headquartered in Kaohsiung City, Taiwan.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Data is available to registered users only
Buy
Sell